MedTrace Logo

Efficacy of Tinoridine in Treating Pain and Inflammation in Adults

NCT01224756 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 342

Last updated 2012-01-12

No results posted yet for this study

Summary

The purpose of this study is to confirm the efficacy of tinoridine hydrochloride (HCL), three times daily (TID), in the treatment of pain and inflammation in patients with acute tonsillitis and/or acute pharyngitis of nonbacterial origin versus placebo.

Conditions

Interventions

DRUG

Tinoridine HCl

Tinoridine HCl 50 mg, orally, 2 capsules three times daily for up to 4 days.

DRUG

Placebo

Tinoridine placebo-matching capsules, orally, 2 capsules three times daily for up to 4 days.

Sponsors & Collaborators

Principal Investigators

  • Professor in ENT-HN · PT. Takeda Indonesia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01224756 on ClinicalTrials.gov